标题
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19
作者
关键词
-
出版物
iScience
Volume 24, Issue 9, Pages 103040
出版商
Elsevier BV
发表日期
2021-08-27
DOI
10.1016/j.isci.2021.103040
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial
- (2021) Saeid Doaei et al. Journal of Translational Medicine
- Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
- (2020) R. Preston Mason et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction
- (2020) Xiaowen Wang et al. Current Diabetes Reports
- Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial
- (2020) Matthew J Budoff et al. EUROPEAN HEART JOURNAL
- Beyond cardiovascular medicine: potential future uses of icosapent ethyl
- (2020) Deepak L Bhatt et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
- (2020) Luca Perico et al. Nature Reviews Nephrology
- Reduction in Revascularization With Icosapent Ethyl
- (2020) Benjamin E. Peterson et al. CIRCULATION
- Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19
- (2020) Pedro-Antonio Regidor et al. MEDICAL HYPOTHESES
- Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation
- (2020) Stefania Lamon-Fava et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease
- (2019) R. Preston Mason Current Atherosclerosis Reports
- Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
- (2019) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients
- (2018) John H. Powers et al. VALUE IN HEALTH
- Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model
- (2018) Alison Han et al. BMC INFECTIOUS DISEASES
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza
- (2013) Masayuki Morita et al. CELL
- Treatment with ω-3 fatty acids reduces serum C-reactive protein concentration
- (2011) Kamran I Muhammad et al. Clinical Lipidology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started